{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:01:03Z","timestamp":1791219663786,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.neurobiolaging.2012.04.017","type":"journal-article","created":{"date-parts":[[2012,5,24]],"date-time":"2012-05-24T05:19:19Z","timestamp":1337836759000},"page":"1-12","source":"Crossref","is-referenced-by-count":189,"title":["Apolipoprotein E \u03b54 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease"],"prefix":"10.1016","volume":"34","author":[{"given":"Adam S.","family":"Fleisher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kewei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Napatkamon","family":"Ayutyanont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Auttawut","family":"Roontiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradeep","family":"Thiyyagura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hillary","family":"Protas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhinay D.","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwan","family":"Sabbagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl H.","family":"Sadowsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reisa A.","family":"Sperling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Mintun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Pontecorvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Edward","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.M.","family":"Doraiswamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith A.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan P.","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel M.","family":"Skovronsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric M.","family":"Reiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2012.04.017_bib1","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1001\/archneur.65.11.1509","article-title":"Frequent amyloid deposition without significant cognitive impairment among the elderly","volume":"65","author":"Aizenstein","year":"2008","journal-title":"Arch. Neurol"},{"key":"10.1016\/j.neurobiolaging.2012.04.017_bib2","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.neurobiolaging.2012.04.017_bib3","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological staging of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol"},{"issue":"suppl 1","key":"10.1016\/j.neurobiolaging.2012.04.017_bib4","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1017\/S1041610297004973","article-title":"Staging of Alzheimer-related cortical destruction","volume":"9","author":"Braak","year":"1997","journal-title":"Int. Psychogeriatr"},{"key":"10.1016\/j.neurobiolaging.2012.04.017_bib5","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jama.2010.2008","article-title":"Use of florbetapir-PET for imaging beta-amyloid pathology","volume":"305","author":"Clark","year":"2011","journal-title":"Jama"},{"key":"10.1016\/j.neurobiolaging.2012.04.017_bib6","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1196\/annals.1297.005","article-title":"The biphasic relationship between regional brain senile plaque and neurofibrillary tangle distributions: modification by age, sex, and APOE polymorphism","volume":"1019","author":"Corder","year":"2004","journal-title":"Ann. N. Y. Acad. Sci"},{"key":"10.1016\/j.neurobiolaging.2012.04.017_bib7","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1007\/s000180050223","article-title":"The role of APOE polymorphisms in late-onset dementias","volume":"54","author":"Corder","year":"1998","journal-title":"Cell. Mol. Life Sci"},{"key":"10.1016\/j.neurobiolaging.2012.04.017_bib8","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2012.04.017_bib9","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S1474-4422(07)70178-3","article-title":"Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria","volume":"6","author":"Dubois","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurobiolaging.2012.04.017_bib10","doi-asserted-by":"crossref","first-page":"15223","DOI":"10.1523\/JNEUROSCI.3252-09.2009","article-title":"One-year brain atrophy evident in healthy aging","volume":"29","author":"Fjell","year":"2009","journal-title":"J. Neurosci"},{"key":"10.1016\/j.neurobiolaging.2012.04.017_bib11","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1001\/archneurol.2011.150","article-title":"Using positron emission tomography and florbetapir f 18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease","volume":"68","author":"Fleisher","year":"2011","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurobiolaging.2012.04.017_bib12","first-page":"821","article-title":"Apolipoprotein-E modulates the cytotoxic effect of beta-amyloid on rat brain endothelium in an isoform-dependent specific manner","volume":"17","author":"Folin","year":"2006","journal-title":"Int. J. Mol. Med"},{"key":"10.1016\/j.neurobiolaging.2012.04.017_bib13","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/ana.410330306","article-title":"Risk factors for late-onset Alzheimer's disease: a population-based, case-control study","volume":"33","author":"Fratiglioni","year":"1993","journal-title":"Ann. Neurol"},{"key":"10.1016\/j.neurobiolaging.2012.04.017_bib14","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1006\/exnr.1998.6860","article-title":"High frequency of apolipoprotein E epsilon4 allele in young individuals with very mild Alzheimer's disease-related neurofibrillary changes","volume":"153","author":"Ghebremedhin","year":"1998","journal-title":"Exp. Neurol"},{"key":"10.1016\/j.neurobiolaging.2012.04.017_bib15","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1212\/WNL.56.12.1696","article-title":"Gender and age modify the association between APOE and AD-related neuropathology","volume":"56","author":"Ghebremedhin","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2012.04.017_bib16","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1212\/01.wnl.0000326146.60732.d6","article-title":"Imaging amyloid deposition in Lewy body diseases","volume":"71","author":"Gomperts","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2012.04.017_bib17","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.biopsych.2010.05.013","article-title":"Progression of cerebral amyloid load is associated with the apolipoprotein E epsilon4 genotype in Alzheimer's disease","volume":"68","author":"Grimmer","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2012.04.017_bib18","doi-asserted-by":"crossref","first-page":"12686","DOI":"10.1523\/JNEUROSCI.3189-09.2009","article-title":"Disruption of functional connectivity in clinically normal older adults harboring amyloid burden","volume":"29","author":"Hedden","year":"2009","journal-title":"J. Neurosci"},{"key":"10.1016\/j.neurobiolaging.2012.04.017_bib19","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/00005072-199710000-00002","article-title":"Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease [editorial]","volume":"56","author":"Hyman","year":"1997","journal-title":"J. Neuropathol. Exp. Neurol"},{"key":"10.1016\/j.neurobiolaging.2012.04.017_bib20","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1093\/brain\/awn016","article-title":"Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease","volume":"131","author":"Ikonomovic","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2012.04.017_bib21","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","article-title":"Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade","volume":"9","author":"Jack","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurobiolaging.2012.04.017_bib22","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1093\/brain\/awq277","article-title":"Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease","volume":"133","author":"Jack","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2012.04.017_bib23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3233\/JAD-2001-3105","article-title":"Amyloid beta40\/42 clearance across the blood-brain barrier following intra-ventricular injections in wild-type, apoE knockout and human apoE3 or E4 expressing transgenic mice","volume":"3","author":"Ji","year":"2001","journal-title":"J. Alzheimers Dis"},{"key":"10.1016\/j.neurobiolaging.2012.04.017_bib24","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.neuron.2008.04.010","article-title":"ApoE promotes the proteolytic degradation of Abeta","volume":"58","author":"Jiang","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2012.04.017_bib25","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1523\/JNEUROSCI.18-01-00195.1998","article-title":"Isoform-specific effect of apolipoprotein E on cell survival and beta-amyloid-induced toxicity in rat hippocampal pyramidal neuronal cultures","volume":"18","author":"Jord\u00e1n","year":"1998","journal-title":"J. Neurosci"},{"key":"10.1016\/j.neurobiolaging.2012.04.017_bib26","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1001\/archpsyc.61.5.518","article-title":"Apolipoprotein E epsilon4 count affects age at onset of Alzheimer disease, but not lifetime susceptibility: The Cache County Study","volume":"61","author":"Khachaturian","year":"2004","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2012.04.017_bib27","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","article-title":"vImaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B","volume":"55","author":"Klunk","year":"2004","journal-title":"Ann. Neurol"},{"key":"10.1016\/j.neurobiolaging.2012.04.017_bib28","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/ana.21696","article-title":"Apolipoprotein E-dependent accumulation of Alzheimer disease-related lesions begins in middle age","volume":"65","author":"Kok","year":"2009","journal-title":"Ann. Neurol"},{"key":"10.1016\/j.neurobiolaging.2012.04.017_bib29","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1212\/01.wnl.0000267428.62582.aa","article-title":"CSF tau\/Abeta42 ratio for increased risk of mild cognitive impairment: a follow-up study","volume":"69","author":"Li","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2012.04.017_bib30","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/0197-4580(96)00112-1","article-title":"Alzheimer A beta neurotoxicity: promotion by antichymotrypsin, ApoE4; inhibition by A beta-related peptides","volume":"17","author":"Ma","year":"1996","journal-title":"Neurobiol. Aging"},{"issue":"suppl","key":"10.1016\/j.neurobiolaging.2012.04.017_bib31","doi-asserted-by":"crossref","first-page":"S183","DOI":"10.1194\/jlr.R800069-JLR200","article-title":"Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer's disease to AIDS","volume":"50","author":"Mahley","year":"2009","journal-title":"J. Lipid Res"},{"key":"10.1016\/j.neurobiolaging.2012.04.017_bib32","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2012.04.017_bib33","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.neurobiolaging.2012.04.017_bib34","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/1206","article-title":"APOE genotype predicts when\u2014not whether\u2014one is predisposed to develop Alzheimer disease","volume":"19","author":"Meyer","year":"1998","journal-title":"Nat. Genet"},{"key":"10.1016\/j.neurobiolaging.2012.04.017_bib35","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/brain\/awn320","article-title":"Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects","volume":"132","author":"Mormino","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2012.04.017_bib36","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ana.21843","article-title":"APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging","volume":"67","author":"Morris","year":"2010","journal-title":"Ann. Neurol"},{"key":"10.1016\/j.neurobiolaging.2012.04.017_bib37","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1016\/j.neuroimage.2010.10.027","article-title":"beta-Amyloid affects frontal and posterior brain networks in normal aging","volume":"54","author":"Oh","year":"2011","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2012.04.017_bib38","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1093\/brain\/awm238","article-title":"Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease","volume":"130","author":"Pike","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2012.04.017_bib39","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X","article-title":"Tangles and plaques in nondemented aging and \u201cpreclinical\u201d Alzheimer's disease","volume":"45","author":"Price","year":"1999","journal-title":"Ann. Neurol"},{"key":"10.1016\/j.neurobiolaging.2012.04.017_bib40","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/cercor\/7.3.268","article-title":"Selective aging of the human cerebral cortex observed in vivo: differential vulnerability of the prefrontal gray matter","volume":"7","author":"Raz","year":"1997","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neurobiolaging.2012.04.017_bib41","doi-asserted-by":"crossref","first-page":"6820","DOI":"10.1073\/pnas.0900345106","article-title":"Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease","volume":"106","author":"Reiman","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2012.04.017_bib42","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1212\/WNL.0b013e318245d295","article-title":"beta-Amyloid burden in healthy aging: regional distribution and cognitive consequences","volume":"78","author":"Rodrigue","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2012.04.017_bib43","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.neurobiolaging.2010.04.007","article-title":"Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging","volume":"31","author":"Rowe","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2012.04.017_bib44","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.bbr.2008.02.016","article-title":"Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior","volume":"192","author":"Selkoe","year":"2008","journal-title":"Behav. Brain Res"},{"key":"10.1016\/j.neurobiolaging.2012.04.017_bib45","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.21610","article-title":"Cerebrospinal fluid biomarker signature in Alzheimer\u2032s Disease Neuroimaging Initiative subjects","volume":"65","author":"Shaw","year":"2009","journal-title":"Ann. Neurol"},{"key":"10.1016\/j.neurobiolaging.2012.04.017_bib46","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/0891988711409410","article-title":"Pittsburgh compound B-negative dementia: a possibility of misdiagnosis of patients with non-alzheimer disease-type dementia as having AD","volume":"24","author":"Shimada","year":"2011","journal-title":"J. Geriatr. Psychiatry Neurol"},{"key":"10.1016\/j.neurobiolaging.2012.04.017_bib47","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1001\/archneurol.2011.77","article-title":"Longitudinal patterns of beta-amyloid deposition in nondemented older adults","volume":"68","author":"Sojkova","year":"2011","journal-title":"Arch. Neurol"},{"key":"10.1016\/j.neurobiolaging.2012.04.017_bib48","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.neurobiolaging.2012.04.017_bib49","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1001\/archneurol.2009.272","article-title":"Cognitive decline and brain volume loss as signatures of cerebral amyloid-beta peptide deposition identified with Pittsburgh compound B: cognitive decline associated with Abeta deposition","volume":"66","author":"Storandt","year":"2009","journal-title":"Arch. Neurol"},{"key":"10.1016\/j.neurobiolaging.2012.04.017_bib50","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","article-title":"Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease","volume":"90","author":"Strittmatter","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2012.04.017_bib51","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3233\/JAD-2010-100129","article-title":"Reduced posterior cingulate mitochondrial activity in expired young adult carriers of the APOE epsilon4 allele, the major late-onset Alzheimer's susceptibility gene","volume":"22","author":"Valla","year":"2010","journal-title":"J. Alzheimers Dis"},{"key":"10.1016\/j.neurobiolaging.2012.04.017_bib52","first-page":"308","article-title":"Effect of apolipoprotein E on biomarkers of amyloid load and neuronal pathology in Alzheimer disease","volume":"67","author":"Vemuri","year":"2010","journal-title":"Ann. Neurol"},{"key":"10.1016\/j.neurobiolaging.2012.04.017_bib53","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ana.22248","article-title":"Longitudinal assessment of Abeta and cognition in aging and Alzheimer disease","volume":"69","author":"Villemagne","year":"2011","journal-title":"Ann. Neurol"},{"key":"10.1016\/j.neurobiolaging.2012.04.017_bib54","first-page":"1030","article-title":"Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro","volume":"145","author":"Wisniewski","year":"1994","journal-title":"Am. J. Pathol"},{"key":"10.1016\/j.neurobiolaging.2012.04.017_bib55","doi-asserted-by":"crossref","first-page":"5312","DOI":"10.1523\/JNEUROSCI.1042-08.2008","article-title":"Human apolipoprotein E redistributes fibrillar amyloid deposition in Tg-SwDI mice","volume":"28","author":"Xu","year":"2008","journal-title":"J. Neurosci"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458012002655?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458012002655?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,29]],"date-time":"2019-06-29T02:31:34Z","timestamp":1561775494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458012002655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0197458012002655"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2012.04.017","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}